Oligonucleotide CDMO Market to Hit $6.73 Billion by 2029 Amid Surge in Outsourced Gene-Based Drug Manufacturing
You have permission to edit this article.
Source: Daily Sun April 04, 2026 09:14 UTC
Loading...
Loading...